Fenofibrate News
Fenofibrate currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Fenofibrate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Pravafenix is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the treatment of mixed hyperlipidaemia in adult patients at high...
- Evidence level: L5
- Predicted indications (20):
- homozygous familial hypercholesterolemia (99.9%)
- obsolete familial combined hyperlipidemia (99.8%)
- hyperlipoproteinemia (99.7%)
- familial hypercholesterolemia (99.6%)
- cholesterol-ester transfer protein deficiency (99.6%)
- hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (99.5%)
- hyperlipidemia (99.5%)
- hyperlipidemia due to hepatic triglyceride lipase deficiency (99.4%)
- familial hyperlipidemia (99.4%)
- hyperlipidemia, familial combined, LPL related (99.4%)
- hypoalphalipoproteinemia (99.4%)
- hypercholesterolemia, autosomal dominant (99.0%)
- hypolipoproteinemia (disease) (98.7%)
- hyperalphalipoproteinemia (97.6%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (97.0%)
- HIV infectious disease (97.0%)
- sitosterolemia (96.9%)
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome (96.8%)
- obsolete susceptibility to ischemic stroke (96.7%)
- brain small vessel disease 1 with or without ocular anomalies (96.7%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.